ISS Backs Cigna-Express Scripts Deal

0 4

Carl Icahn may have bother discovering sufficient allies to dam Cigna Corp.’s $54 billion deal to purchase pharmacy-benefit supervisor Categorical Scripts Holding Co.

Institutional Shareholder Companies, one among two main proxy-advisory corporations, is recommending that Cigna shareholders assist the deal in a vote later this month, based on a report ISS purchasers obtained Friday and considered by The Wall Avenue Journal.


Supply hyperlink –

You might also like

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.